Metabolic abnormalities associated with HIV infection and antiretroviral therapy. (Q46191354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Metabolic abnormalities associated with HIV infection and antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

anti-retroviral agent

0 references

author

Carl Fichtenbaum

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Carl J Fichtenbaum

series ordinal

1

1 reference

20 December 2017

http://europepmc.org/abstract/MED/19094829

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

Current infectious disease reports

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

84-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

18 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-009-0012-8

A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation

21 January 2018

1 reference

12 December 2020

Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study

1 reference

12 December 2020

Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy

1 reference

12 December 2020

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

1 reference

12 December 2020

Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study

1 reference

12 December 2020

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

1 reference

12 December 2020

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides

1 reference

12 December 2020

Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase

1 reference

12 December 2020

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy

1 reference

12 December 2020

Standards of medical care in diabetes

1 reference

12 December 2020

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

1 reference

12 December 2020

Fat distribution in men with HIV infection

1 reference

12 December 2020

CD4+ count-guided interruption of antiretroviral treatment

1 reference

12 December 2020

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study

1 reference

12 December 2020

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial

1 reference

12 December 2020

Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia

1 reference

12 December 2020

Severe premature coronary artery disease with protease inhibitors

1 reference

12 December 2020

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial

1 reference

12 December 2020

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically

1 reference

12 December 2020

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers

1 reference

12 December 2020

Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study

1 reference

12 December 2020

Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

1 reference

12 December 2020

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

1 reference

12 December 2020

Tolerability and safety of HIV protease inhibitors in adults

1 reference

12 December 2020

Switching effective antiretroviral therapy: a review.

1 reference

12 December 2020

A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution

1 reference

12 December 2020

Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity

1 reference

12 December 2020

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

12 December 2020

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

12 December 2020

Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy

1 reference

12 December 2020

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

1 reference

12 December 2020

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

1 reference

12 December 2020

Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial

1 reference

12 December 2020

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

12 December 2020

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors

1 reference

12 December 2020

State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary

1 reference

12 December 2020

A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.

1 reference

12 December 2020

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

1 reference

12 December 2020

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

12 December 2020

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

1 reference

12 December 2020

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

1 reference

12 December 2020

10.1007/S11908-009-0012-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094829%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference